153 related articles for article (PubMed ID: 23509994)
1. High disease activity in ankylosing spondylitis is associated with increased serum sclerostin level and decreased wingless protein-3a signaling but is not linked with greater structural damage.
Korkosz M; Gąsowski J; Leszczyński P; Pawlak-Buś K; Jeka S; Kucharska E; Grodzicki T
BMC Musculoskelet Disord; 2013 Mar; 14():99. PubMed ID: 23509994
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers of bone metabolism in ankylosing spondylitis in relation to osteoproliferation and osteoporosis.
Klingberg E; Nurkkala M; Carlsten H; Forsblad-d'Elia H
J Rheumatol; 2014 Jul; 41(7):1349-56. PubMed ID: 24931960
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis.
Taylan A; Sari I; Akinci B; Bilge S; Kozaci D; Akar S; Colak A; Yalcin H; Gunay N; Akkoc N
BMC Musculoskelet Disord; 2012 Oct; 13():191. PubMed ID: 23025387
[TBL] [Abstract][Full Text] [Related]
4. Sclerostin rather than Dickkopf-1 is associated with mSASSS but not with disease activity score in patients with ankylosing spondylitis.
Sun W; Tian L; Jiang L; Zhang S; Zhou M; Zhu J; Xue J
Clin Rheumatol; 2019 Apr; 38(4):989-995. PubMed ID: 30443790
[TBL] [Abstract][Full Text] [Related]
5. Effect of tumour necrosis factor-α inhibitor on serum level of dickkopf-1 protein and bone morphogenetic protein-7 in ankylosing spondylitis patients with high disease activity.
Korkosz M; Gąsowski J; Leszczyński P; Pawlak-Buś K; Jeka S; Siedlar M; Grodzicki T
Scand J Rheumatol; 2014; 43(1):43-8. PubMed ID: 24447112
[TBL] [Abstract][Full Text] [Related]
6. Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?
Saad CG; Ribeiro AC; Moraes JC; Takayama L; Goncalves CR; Rodrigues MB; de Oliveira RM; Silva CA; Bonfa E; Pereira RM
Arthritis Res Ther; 2012 Oct; 14(5):R216. PubMed ID: 23062122
[TBL] [Abstract][Full Text] [Related]
7. Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study.
Perrotta FM; Ceccarelli F; Barbati C; Colasanti T; De Socio A; Scriffignano S; Alessandri C; Lubrano E
J Immunol Res; 2018; 2018():9101964. PubMed ID: 29854850
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of Dkk-1, sclerostin and VEGF in patients with ankylosing spondylitis and their association with smoking, and clinical, inflammatory and radiographic parameters.
Sakellariou GT; Iliopoulos A; Konsta M; Kenanidis E; Potoupnis M; Tsiridis E; Gavana E; Sayegh FE
Joint Bone Spine; 2017 May; 84(3):309-315. PubMed ID: 27369645
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between sclerostin level and radiographic changes in patients with ankylosing spondylitis].
Xie J; Yu X
Zhonghua Yi Xue Za Zhi; 2015 May; 95(17):1300-4. PubMed ID: 26081658
[TBL] [Abstract][Full Text] [Related]
10. Circulating periostin levels in patients with AS: association with clinical and radiographic variables, inflammatory markers and molecules involved in bone formation.
Sakellariou GT; Anastasilakis AD; Bisbinas I; Oikonomou D; Gerou S; Polyzos SA; Sayegh FE
Rheumatology (Oxford); 2015 May; 54(5):908-14. PubMed ID: 25349442
[TBL] [Abstract][Full Text] [Related]
11. Serum Sclerostin and Bone Morphogenetic Protein-2 Levels in Patients with Ankylosing Spondylitis: A Meta-Analysis.
Yang J; Xu S; Chen M; Yuan Y; Zhang X; Ma Y; Wu M; Han R; Hu X; Liu R; Deng J; Guan S; Gao X; Pan M; Xu S; Shuai Z; Jiang S; Guan S; Chen L; Pan F
Calcif Tissue Int; 2019 Jul; 105(1):37-50. PubMed ID: 30911810
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of periostin and factors associated with new bone formation in ankylosing spondylitis: Periostin may be associated with the Wnt pathway.
Solmaz D; Uslu S; Kozacı D; Karaca N; Bulbul H; Tarhan EF; Ozmen M; Can G; Akar S
Int J Rheum Dis; 2018 Feb; 21(2):502-509. PubMed ID: 28941122
[TBL] [Abstract][Full Text] [Related]
13. Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis.
Rossini M; Viapiana O; Idolazzi L; Ghellere F; Fracassi E; Troplini S; Povino MR; Kunnathully V; Adami S; Gatti D
Calcif Tissue Int; 2016 May; 98(5):438-45. PubMed ID: 26645432
[TBL] [Abstract][Full Text] [Related]
14. Sclerostin and Dkk-1 in patients with ankylosing spondylitis.
Ustun N; Tok F; Kalyoncu U; Motor S; Yuksel R; Yagiz AE; Guler H; Turhanoglu AD
Acta Reumatol Port; 2014; 39(2):146-51. PubMed ID: 25111416
[TBL] [Abstract][Full Text] [Related]
15. Fetuin-A is related to syndesmophytes in patients with ankylosing spondylitis: a case control study.
Tuylu T; Sari I; Solmaz D; Kozaci DL; Akar S; Gunay N; Onen F; Akkoc N
Clinics (Sao Paulo); 2014 Dec; 69(10):688-93. PubMed ID: 25518021
[TBL] [Abstract][Full Text] [Related]
16. Assessment of semaphorin 3A and its role in bone remodelling in a group of ankylosing spondylitis patients.
Perrotta FM; Ceccarelli F; Barbati C; Colasanti T; Montepaone M; Alessandri C; Valesini G; Lubrano E
Clin Exp Rheumatol; 2017; 35(2):313-316. PubMed ID: 27782869
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of serum fibroblast growth factor-23 in patients with axial spondyloarthritis and its association with sclerostin, inflammation, and spinal damage.
Gercik O; Solmaz D; Coban E; Iptec BO; Avcioglu G; Bayindir O; Kabadayi G; Topal FE; Kozaci D; Akar S
Rheumatol Int; 2019 May; 39(5):835-840. PubMed ID: 30968207
[TBL] [Abstract][Full Text] [Related]
18. High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis.
Heiland GR; Appel H; Poddubnyy D; Zwerina J; Hueber A; Haibel H; Baraliakos X; Listing J; Rudwaleit M; Schett G; Sieper J
Ann Rheum Dis; 2012 Apr; 71(4):572-4. PubMed ID: 22186710
[TBL] [Abstract][Full Text] [Related]
19. Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis.
Appel H; Ruiz-Heiland G; Listing J; Zwerina J; Herrmann M; Mueller R; Haibel H; Baraliakos X; Hempfing A; Rudwaleit M; Sieper J; Schett G
Arthritis Rheum; 2009 Nov; 60(11):3257-62. PubMed ID: 19877044
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid therapy causes contradictory changes of serum Wnt signaling-related molecules in systemic autoimmune diseases.
Kawazoe M; Kaneko K; Shikano K; Kusunoki N; Nanki T; Kawai S
Clin Rheumatol; 2018 Aug; 37(8):2169-2178. PubMed ID: 28551822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
